Pharmaceutical Solvent Market Regional Analysis:
North America Market Insights
North America industry is expected to account for largest revenue share of 36% by 2035, owing to a large number of developed pharmaceutical industries in the region. Further, increased spending on pharmaceutical research and development is expected to stimulate the use of pharmaceutical solvents in the region. Congressional Budget Office reports that a total of USD 83 billion was spent by the pharmaceutical industry on research and development in 2019. Moreover, the rising sales and demand for pharmaceutical products are projected to propel the demand for pharmaceutical solvents in the region.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of pharmaceutical solvent is assessed at USD 5.39 billion.
The global pharmaceutical solvent market size was over USD 5.18 billion in 2025 and is anticipated to witness a CAGR of around 4.5%, crossing USD 8.04 billion revenue by 2035.
The North America pharmaceutical solvent market is anticipated to secure a 36% share by 2035, driven by the large number of developed pharmaceutical industries in the region.
Key players in the market include BASF SE, Bayer AG, Clariant International Ltd, Exxon Mobil Corporation., Dow Chemical Company, Brenntag SE, Pon Pure Chemicals Group, Mitsui Chemicals, Inc., LyondellBasell Industries Holdings B.V., PPG Industries, Inc.
